Discontinued — last reported Q4 '25
Fastenal Interest Paid decreased by 22.2% to $700.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 53.3%, from $1.50M to $700.00K. Over 4 years (FY 2021 to FY 2025), Interest Paid shows a downward trend with a -9.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.60M | $2.60M | $2.30M | $2.30M | $2.70M | $4.20M | $4.10M | $5.10M | $3.10M | $2.10M | $1.90M | $2.40M | $1.80M | $1.80M | $1.80M | $1.50M | $2.70M | $1.50M | $900.00K | $700.00K |
| QoQ Change | — | +0.0% | -11.5% | +0.0% | +17.4% | +55.6% | -2.4% | +24.4% | -39.2% | -32.3% | -9.5% | +26.3% | -25.0% | +0.0% | +0.0% | -16.7% | +80.0% | -44.4% | -40.0% | -22.2% |
| YoY Change | — | — | — | — | +3.8% | +61.5% | +78.3% | +121.7% | +14.8% | -50.0% | -53.7% | -52.9% | -41.9% | -14.3% | -5.3% | -37.5% | +50.0% | -16.7% | -50.0% | -53.3% |